Literature DB >> 30529671

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

Vinod H Thourani1, Sean M O'Brien2, John J Kelly3, David J Cohen4, Eric D Peterson2, Michael J Mack5, David M Shahian6, Frederick L Grover7, John D Carroll8, J Matthew Brennan2, Jessica Forcillo9, Suzanne V Arnold4, Sreekanth Vemulapalli2, Susan Fitzgerald10, David R Holmes11, Joseph E Bavaria3, Fred H Edwards12.   

Abstract

BACKGROUND: Stroke is a serious complication after transcatheter aortic valve replacement (TAVR), yet predictive models are not available. A new risk model for in-hospital stroke after TAVR was developed and used to estimate site-specific performance.
METHODS: We included 97,600 TAVR procedures from 521 sites in The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry from July 2014 to June 2017. Association between baseline covariates and in-hospital stroke was estimated by logistic regression. Discrimination was evaluated by C-statistic. Calibration was tested internally via cross-validation. Hierarchical modeling was used to estimate risk-adjusted site-specific performance.
RESULTS: Median age was 82 years, 44,926 (46.0%) were women, and 1,839 (1.9%) had in-hospital stroke. Covariates associated with stroke (odds ratio) included transapical access (1.44), access excluding transapical and transfemoral (1.77), prior stroke (1.57), prior transient ischemic attack (1.50), preprocedural shock, inotropes or mechanical assist device (1.48), smoking (1.28), porcelain aorta (1.23), peripheral arterial disease (1.21), age per 5 years (1.11), glomerular filtration rate per 5 mL/min (0.97), body surface area per m2 (0.55 male; 0.43 female), and prior aortic valve (0.78) and nonaortic valvular (0.42) procedures. The C-statistic was 0.622. Calibration curves demonstrated agreement between observed and expected stroke rates. Hierarchical modeling showed 10 (1.9%) centers with significantly higher odds ratios for in-hospital stroke than their peers.
CONCLUSIONS: A risk model for in-hospital stroke after TAVR was developed from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry and used to estimate site-specific stroke performance. This model can serve as a valuable resource for quality improvement, clinical decision making, and patient counseling.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30529671      PMCID: PMC6726434          DOI: 10.1016/j.athoracsur.2018.11.013

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  37 in total

1.  Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.

Authors:  Eugene H Blackstone; Rakesh M Suri; Jeevanantham Rajeswaran; Vasilis Babaliaros; Pamela S Douglas; William F Fearon; D Craig Miller; Rebecca T Hahn; Samir Kapadia; Ajay J Kirtane; Susheel K Kodali; Michael Mack; Wilson Y Szeto; Vinod H Thourani; E Murat Tuzcu; Mathew R Williams; Jodi J Akin; Martin B Leon; Lars G Svensson
Journal:  Circulation       Date:  2015-04-01       Impact factor: 29.690

2.  Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Philipp Döttger; Kathrine Mori; Björn Plicht; Daniel Wendt; Lars Bergmann; Eva Kottenberg; Marc Schlamann; Petra Mummel; Dagny Holle; Matthias Thielmann; Heinz G Jakob; Thomas Konorza; Gerd Heusch; Raimund Erbel; Holger Eggebrecht
Journal:  Circulation       Date:  2012-08-16       Impact factor: 29.690

3.  The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies.

Authors:  John D Carroll; Fred H Edwards; Danica Marinac-Dabic; Ralph G Brindis; Frederick L Grover; Eric D Peterson; E Murat Tuzcu; David M Shahian; John S Rumsfeld; Cynthia M Shewan; Kathleen Hewitt; David R Holmes; Michael J Mack
Journal:  J Am Coll Cardiol       Date:  2013-05-01       Impact factor: 24.094

4.  Predictive risk models for transcatheter procedures: how should they be created?

Authors:  Daniel Hernández-Vaquero; Rocío Díaz; César Morís
Journal:  J Thorac Cardiovasc Surg       Date:  2014-10       Impact factor: 5.209

Review 5.  Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients.

Authors:  Holger Eggebrecht; Axel Schmermund; Thomas Voigtländer; Philipp Kahlert; Raimund Erbel; Rajendra H Mehta
Journal:  EuroIntervention       Date:  2012-05-15       Impact factor: 6.534

6.  Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.

Authors:  Samir R Kapadia; Susheel Kodali; Raj Makkar; Roxana Mehran; Ronald M Lazar; Robert Zivadinov; Michael G Dwyer; Hasan Jilaihawi; Renu Virmani; Saif Anwaruddin; Vinod H Thourani; Tamim Nazif; Norman Mangner; Felix Woitek; Amar Krishnaswamy; Stephanie Mick; Tarun Chakravarty; Mamoo Nakamura; James M McCabe; Lowell Satler; Alan Zajarias; Wilson Y Szeto; Lars Svensson; Maria C Alu; Roseann M White; Carlye Kraemer; Azin Parhizgar; Martin B Leon; Axel Linke
Journal:  J Am Coll Cardiol       Date:  2016-11-01       Impact factor: 24.094

7.  A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation.

Authors:  Edgar L W Tay; Ronen Gurvitch; Namal Wijesinghe; Fabian Nietlispach; Fabian Nielispach; David Wood; Anson Cheung; Jian Ye; Samuel V Lichtenstein; Ronald Carere; Christopher Thompson; John G Webb
Journal:  JACC Cardiovasc Interv       Date:  2011-12       Impact factor: 11.195

8.  Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement.

Authors:  Wilson Y Szeto; John G Augoustides; Nimesh D Desai; Patrick Moeller; Michael L McGarvey; Elizabeth Walsh; Amr Bannan; Howard C Herrmann; Joseph E Bavaria
Journal:  J Card Surg       Date:  2011-07       Impact factor: 1.620

9.  Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Michael J Reardon; Nicolas M Van Mieghem; Jeffrey J Popma; Neal S Kleiman; Lars Søndergaard; Mubashir Mumtaz; David H Adams; G Michael Deeb; Brijeshwar Maini; Hemal Gada; Stanley Chetcuti; Thomas Gleason; John Heiser; Rüdiger Lange; William Merhi; Jae K Oh; Peter S Olsen; Nicolo Piazza; Mathew Williams; Stephan Windecker; Steven J Yakubov; Eberhard Grube; Raj Makkar; Joon S Lee; John Conte; Eric Vang; Hang Nguyen; Yanping Chang; Andrew S Mugglin; Patrick W J C Serruys; Arie P Kappetein
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

10.  Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy.

Authors:  Didier Tchetche; Bruno Farah; Leonardo Misuraca; Adele Pierri; Olivier Vahdat; Corinne Lereun; Nicolas Dumonteil; Thomas Modine; Marc Laskar; Helene Eltchaninoff; Dominique Himbert; Bernard Iung; Emmanuel Teiger; Karine Chevreul; Michel Lievre; Thierry Lefevre; Patrick Donzeau-Gouge; Martine Gilard; Jean Fajadet
Journal:  JACC Cardiovasc Interv       Date:  2014-09-17       Impact factor: 11.195

View more
  9 in total

1.  Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States.

Authors:  Mohamad Alkhouli; Fahad Alqahtani; Alyssa Hartsell Harris; Samuel F Hohmann; Charanjit S Rihal
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

2.  Cerebrovascular Events after Transcatheter Aortic Valve Replacement: The Difficulty in Predicting the Unpredictable.

Authors:  Oliver Maier; Georg Bosbach; Kerstin Piayda; Shazia Afzal; Amin Polzin; Ralf Westenfeld; Christian Jung; Malte Kelm; Tobias Zeus; Verena Veulemans
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

Review 3.  A systematic review and meta-analysis of the cerebrovascular event incidence after transcatheter aortic valve implantation.

Authors:  Christian Frerker; Tobias Schmidt; Max M Meertens; Sascha Macherey; Sebastiaan Asselberghs; Samuel Lee; Jan Hendrik Schipper; Barend Mees; Ingo Eitel; Stephan Baldus
Journal:  Clin Res Cardiol       Date:  2022-03-17       Impact factor: 6.138

Review 4.  Advances in transcatheter aortic valve replacement.

Authors:  Tomo Ando; Alexandros Briasoulis; Sidakpal Panaich
Journal:  J Geriatr Cardiol       Date:  2019-09       Impact factor: 3.327

Review 5.  Risk Stratification for Transcatheter Aortic Valve Replacement.

Authors:  Abdul Ahad Khan; Ghulam Murtaza; Muhammad F Khalid; Furqan Khattak
Journal:  Cardiol Res       Date:  2019-11-24

6.  Center Variability in Medicare Claims-Based Publicly Reported Transcatheter Aortic Valve Replacement Outcome Measures.

Authors:  Michael P Thompson; Hechuan Hou; Alexander A Brescia; Francis D Pagani; Devraj Sukul; Jeffrey S McCullough; Donald S Likosky
Journal:  J Am Heart Assoc       Date:  2021-10-23       Impact factor: 5.501

7.  Safety of Transcatheter Aortic Valve Replacement in Patients with Aortic Aneurysm: A Propensity-Matched Analysis.

Authors:  Justin K Ugwu; Jideofor K Ndulue; Khaled A Sherif; Samson Alliu; Ayman Elbadawi; Tuncay Taskesen; Doha Hussein; Judith N Ugwu Erugo; Khaled F Chatila; Ahmed Almustafa; Wissam I Khalife; Paul N Kumfa
Journal:  Cardiol Ther       Date:  2022-03-06

8.  Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry.

Authors:  Neel M Butala; Raj Makkar; Eric A Secemsky; Dianne Gallup; Guillaume Marquis-Gravel; Andrzej S Kosinski; Sreekanth Vemulapalli; Javier A Valle; Steven M Bradley; Tarun Chakravarty; Robert W Yeh; David J Cohen
Journal:  Circulation       Date:  2021-02-23       Impact factor: 39.918

9.  Preliminary Results of the Outpatient Endovascular and Interventional Society National Registry.

Authors:  Samuel S Ahn; Robert W Tahara; Lauren E Jones; Jeffrey G Carr; John Blebea
Journal:  J Endovasc Ther       Date:  2020-08-19       Impact factor: 3.487

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.